![](/img/cover-not-exists.png)
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Susan C. Modesitt, Michael Sill, James S. Hoffman, David P. BenderVolume:
109
Year:
2008
Language:
english
Pages:
5
DOI:
10.1016/j.ygyno.2008.01.009
File:
PDF, 251 KB
english, 2008